Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sanofi ( Sanofi Pasteur, a Sanofi Company )
ClinicalTrials.gov Identifier:
NCT00875524
First received: April 2, 2009
Last updated: January 9, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)